Avanos Medical Inc (AVNS)

NYSE
Currency in USD
12.31
-0.17(-1.36%)
Closed·
After Hours
12.310.00(0.00%)
·
AVNS Scorecard
Full Analysis
High shareholder yield
AVNS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.1212.44
52 wk Range
11.8425.36
Key Statistics
Edit
Prev. Close
12.48
Open
12.28
Day's Range
12.12-12.44
52 wk Range
11.84-25.36
Volume
361.53K
Average Volume (3m)
526.69K
1-Year Change
-37.98%
Book Value / Share
18.25
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AVNS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
14.00
Upside
+13.73%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Avanos Medical Inc Company Profile

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; OrthogenRx knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Avanos Medical Inc SWOT Analysis


Transformation Hurdles
Avanos Medical faces challenges in its three-year plan, with mixed segment performance and leadership changes impacting its strategic direction
Financial Resilience
Despite revenue shortfalls, Avanos demonstrates financial strength with cost-saving measures and positive free cash flow generation
Market Valuation
Explore how Avanos' stock trades at 12x projected 2025 EPS, reflecting cautious optimism amidst ongoing transformation efforts
Growth Prospects
Delve into Avanos' potential in the Digestive Health segment, offsetting challenges and supporting ambitious 2025 financial targets
Read full SWOT analysis

Avanos Medical Inc Earnings Call Summary for Q1/2025

  • Q1 2025 EPS of $0.26 beat forecast by 44.4%, revenue of $167.5M exceeded expectations, driving 6.03% stock increase
  • Organic sales grew 2.8%, with strong performance in Specialty Nutrition Systems and Pain Management segments
  • Full-year revenue estimate maintained at $665M-$685M, adjusted EPS projected at $0.75-$0.95
  • Company faces $15M increase in tariff-related costs, plans to transition manufacturing out of China by H1 2026
  • Healthy liquidity with $97M cash on hand, debt at $107M; financial health score rated 'GOOD' by InvestingPro
Last Updated: 07/05/2025, 12:32 am
Read Full Transcript

Compare AVNS to Peers and Sector

Metrics to compare
AVNS
Peers
Sector
Relationship
P/E Ratio
−1.5x−5.8x−0.4x
PEG Ratio
0.000.000.00
Price/Book
0.7x2.7x2.6x
Price / LTM Sales
0.8x2.9x2.9x
Upside (Analyst Target)
13.7%75.0%51.7%
Fair Value Upside
Unlock3.4%9.5%Unlock

Analyst Ratings

0 Buy
2 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 14.00
(+13.73% Upside)

Earnings

Latest Release
May 06, 2025
EPS / Forecast
0.26 / 0.18
Revenue / Forecast
167.50M / 162.00M
EPS Revisions
Last 90 days

People Also Watch

128.50
ATGE
+0.03%
2.22
AGL
+0.91%
2.900
ORGO
-2.36%
55.40
CNMD
-1.18%
9.45
ANGO
+0.43%

FAQ

What Is the Avanos Medical (AVNS) Stock Price Today?

The Avanos Medical stock price today is 12.31

What Stock Exchange Does Avanos Medical Trade On?

Avanos Medical is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Avanos Medical?

The stock symbol for Avanos Medical is "AVNS."

What Is the Avanos Medical Market Cap?

As of today, Avanos Medical market cap is 569.26M.

What Is Avanos Medical's Earnings Per Share (TTM)?

The Avanos Medical EPS (TTM) is -8.27.

When Is the Next Avanos Medical Earnings Date?

Avanos Medical will release its next earnings report on 11 Aug 2025.

From a Technical Analysis Perspective, Is AVNS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Avanos Medical Stock Split?

Avanos Medical has split 0 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.